184 related articles for article (PubMed ID: 11972038)
1. Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle.
Sugarman MC; Yamasaki TR; Oddo S; Echegoyen JC; Murphy MP; Golde TE; Jannatipour M; Leissring MA; LaFerla FM
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6334-9. PubMed ID: 11972038
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic accumulation of APP in fast twitch muscle of IBM patients and a transgenic model.
Sugarman MC; Kitazawa M; Baker M; Caiozzo VJ; Querfurth HW; LaFerla FM
Neurobiol Aging; 2006 Mar; 27(3):423-32. PubMed ID: 15950323
[TBL] [Abstract][Full Text] [Related]
3. Transgenic expression of beta-APP in fast-twitch skeletal muscle leads to calcium dyshomeostasis and IBM-like pathology.
Moussa CE; Fu Q; Kumar P; Shtifman A; Lopez JR; Allen PD; LaFerla F; Weinberg D; Magrane J; Aprahamian T; Walsh K; Rosen KM; Querfurth HW
FASEB J; 2006 Oct; 20(12):2165-7. PubMed ID: 16940437
[TBL] [Abstract][Full Text] [Related]
4. Intracellular β-amyloid accumulation leads to age-dependent progression of Ca2+ dysregulation in skeletal muscle.
Lopez JR; Shtifman A
Muscle Nerve; 2010 Nov; 42(5):731-8. PubMed ID: 20665519
[TBL] [Abstract][Full Text] [Related]
5. Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice.
Kitazawa M; Green KN; Caccamo A; LaFerla FM
Am J Pathol; 2006 Jun; 168(6):1986-97. PubMed ID: 16723713
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dysfunction in skeletal muscle of amyloid precursor protein-overexpressing mice.
Boncompagni S; Moussa CE; Levy E; Pezone MJ; Lopez JR; Protasi F; Shtifman A
J Biol Chem; 2012 Jun; 287(24):20534-44. PubMed ID: 22518836
[TBL] [Abstract][Full Text] [Related]
7. Beta-amyloid peptide expression is sufficient for myotube death: implications for human inclusion body myopathy.
Querfurth HW; Suhara T; Rosen KM; McPhie DL; Fujio Y; Tejada G; Neve RL; Adelman LS; Walsh K
Mol Cell Neurosci; 2001 May; 17(5):793-810. PubMed ID: 11358479
[TBL] [Abstract][Full Text] [Related]
8. Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles.
Vattemi G; Engel WK; McFerrin J; Askanas V
J Neurochem; 2003 Jun; 85(6):1539-46. PubMed ID: 12787072
[TBL] [Abstract][Full Text] [Related]
9. Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis.
Chen X; Ghribi O; Geiger JD
Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R829-35. PubMed ID: 18216139
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice expressing the human C99 terminal fragment of betaAPP: effects on cytochrome oxidase activity in skeletal muscle and brain.
Strazielle C; Dumont M; Fukuchi K; Lalonde R
J Chem Neuroanat; 2004 Jul; 27(4):237-46. PubMed ID: 15261330
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis.
Vattemi G; Nogalska A; King Engel W; D'Agostino C; Checler F; Askanas V
Acta Neuropathol; 2009 May; 117(5):569-74. PubMed ID: 19280202
[TBL] [Abstract][Full Text] [Related]
12. NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in A beta PP-overexpressing cultured human muscle fibers.
Wojcik S; Engel WK; Yan R; McFerrin J; Askanas V
Acta Neuropathol; 2007 Nov; 114(5):517-26. PubMed ID: 17764014
[TBL] [Abstract][Full Text] [Related]
13. Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouse.
Luo YB; Johnsen RD; Griffiths L; Needham M; Fabian VA; Fletcher S; Wilton SD; Mastaglia FL
Int J Exp Pathol; 2013 Dec; 94(6):418-25. PubMed ID: 24205796
[TBL] [Abstract][Full Text] [Related]
14. Cultured inclusion-body myositis muscle fibers do not accumulate beta-amyloid precursor protein and can be innervated.
McFerrin J; Engel WK; Askanas V
Neurology; 1999 Dec; 53(9):2184-7. PubMed ID: 10599804
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis.
Jin LW; Hearn MG; Ogburn CE; Dang N; Nochlin D; Ladiges WC; Martin GM
Am J Pathol; 1998 Dec; 153(6):1679-86. PubMed ID: 9846957
[TBL] [Abstract][Full Text] [Related]
16. Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers.
Wójcik S; Engel WK; McFerrin J; Askanas V
Acta Neuropathol; 2005 Aug; 110(2):173-7. PubMed ID: 15983828
[TBL] [Abstract][Full Text] [Related]
17. Does overexpression of betaAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease? Clues from inclusion body myositis, cultured human muscle, and transgenic mice.
Askanas V; Engel WK
Am J Pathol; 1998 Dec; 153(6):1673-7. PubMed ID: 9846956
[No Abstract] [Full Text] [Related]
18. Novel demonstration of amyloid-β oligomers in sporadic inclusion-body myositis muscle fibers.
Nogalska A; D'Agostino C; Engel WK; Klein WL; Askanas V
Acta Neuropathol; 2010 Nov; 120(5):661-6. PubMed ID: 20711838
[TBL] [Abstract][Full Text] [Related]
19. Enhanced accumulation of phosphorylated alpha-synuclein in double transgenic mice expressing mutant beta-amyloid precursor protein and presenilin-1.
Kurata T; Kawarabayashi T; Murakami T; Miyazaki K; Morimoto N; Ohta Y; Takehisa Y; Nagai M; Ikeda M; Matsubara E; Westaway D; Hyslop PS; Harigaya Y; Kamiya T; Shoji M; Abe K
J Neurosci Res; 2007 Aug; 85(10):2246-52. PubMed ID: 17526016
[TBL] [Abstract][Full Text] [Related]
20. Impaired innervation of cultured human muscle overexpressing betaAPP experimentally and genetically: relevance to inclusion-body myopathies.
McFerrin J; Engel WK; Askanas V
Neuroreport; 1998 Oct; 9(14):3201-5. PubMed ID: 9831451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
